Life sciences companies need to draw on the tools and protections in their supplier contracts to maintain continuity and minimize disruption.

The importation of fake and fraudulent medical supplies must be stopped.

What lessons did the healthcare supply chain learn from the COVID-19 pandemic? 

The prescription for getting well lies in a true partnership between healthcare logistics and the supply chain.

A little-known federal agency in charge of stockpiling vaccines and mobilizing supplies in health emergencies is being reorganized to apply lessons learned in the Covid pandemic.

Biogen Inc.’s new chief executive officer outlined some of his first steps toward his vision for the biotechnology company with plans to boost investment in new drugs the company is developing for Alzheimer’s disease, lupus and other illnesses.

Through its savvy but legal exploitation of the U.S. patent system, Humira’s manufacturer, AbbVie, was able to block competitors from entering the market.

The country has so far relied almost solely on homegrown medicines and vaccines to shore up immunity and treat COVID patients.